SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Huang, Y.-M.
Right arrow Articles by Link, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.-M.
Right arrow Articles by Link, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden

Yu-Min Huang

Division of Neuroimmunology, Neurotec Department, Karolinska Institute, Stockholm, Sweden, yu-min.huang{at}neurotec.ki.se

Xuan Liu

Division of Neuroimmunology, Neurotec Department, Karolinska Institute, Stockholm, Sweden

Knut Steffensen

Department of Biosciences, Karolinska Institute at NOVUM, Huddinge, Sweden

Alessandra Sanna

Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Giannina Arru

Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Maria Laura Fois

Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Giulio Rosati

Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Stefano Sotgiu

Institute of Clinical Neurology, University of Sassari, Sassari, Italy

Hans Link

Division of Neuroimmunology, Neurotec Department, Karolinska Institute, Stockholm, Sweden

Subjects from Sardinia, Italy, are relatively homogeneous compared to Swedes. Although ethnically distant, both populations have similarly high multiple sclerosis (MS) incidence rates. Pro- and anti-inflammatory cytokines and their receptors, signalling molecules and other immune response-associated factors might influence MS pathogenesis, though definite proof is missing. The study of populations with similar MS incidence but different genetic and environmental background could make possible the definition of factors that relate to such background differences. We selected untreated female MS patients from Sassari, Sardinia, and Stockholm, Sweden, and corresponding sexand age-matched healthy controls (HC), to study blood mononuclear cells (MNC) for mRNA expression of 20 immune response-related genes considered relevant in MS, employing real-time PCR. Higher expression of IL-12p40 mRNA was confined to MS from both Sassari and Stockholm, compared to corresponding HC. MS patients from Sassari, but not Stockholm, expressed higher TNF-a compared to corresponding HC. MS patients from Stockholm, but not Sassari, expressed higher IL-6. Indoleamine 2,3 dioxygenase (IDO), a molecule necessary in tolerance induction, was lower in MS from Stockholm compared to corresponding HC. This was not observed in Sassari. No differences were detected for other members of the IL-12 family, other Th1 and Th2 cytokines, and the signalling molecules Stat 4 and 6. The results corroborate a pro-inflammatory state in MS as reflected by high expression of IL-12, TNF-a and IL-6, although the extent of expression of TNF-a, IL-6 and IDO differs between strictly matched MS patients from different high-incidence areas. This might result from genetic and/or environmental differences. They may account for some of the discrepancies regarding immune response-related molecules previously reported in MS. In conclusion, a pro-inflammatory state exists in MS patients from Sassari as well as Stockholm. The changes of pro-inflammatory and other immune response-related variables differ however between the two MS populations. This may be attributed to the genetic and/or environmental background.

Key Words: IDO • IL-6 • IL-12 • multiple sclerosis • RT-PCR • TNF-{alpha}

Multiple Sclerosis, Vol. 11, No. 1, 16-23 (2005)
DOI: 10.1191/1352458505ms1127oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
A Sanna, Y. Huang, G Arru, M. Fois, H Link, G Rosati, and S Sotgiu
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1
Multiple Sclerosis, November 1, 2008; 14(9): 1199 - 1207.
[Abstract] [PDF]



Advertisement